Johnson & Johnson (NYSE: JNJ) is -2.32% lower on its value in year-to-date trading and has touched a low of $143.13 and a high of $168.85 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The JNJ stock was last observed hovering at around $153.00 in the last trading session, with the day’s gains setting it 0.11%.
Currently trading at $153.11, the stock is -2.51% and -4.66% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 7.59 million and changing 0.07% at the moment leaves the stock -1.77% off its SMA200. JNJ registered 2.13% gain for a year compared to 6-month gain of -0.25%. The firm has a 50-day simple moving average (SMA 50) of $160.5896 and a 200-day simple moving average (SMA200) of $155.86674.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -6.33% loss in the last 1 month and extending the period to 3 months gives it a -5.69%, and is -0.08% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 1.68% over the week and 1.49% over the month.
Johnson & Johnson (JNJ) has around 131900 employees, a market worth around $368.63B and $87.69B in sales. Current P/E ratio is 25.31 and Fwd P/E is 14.46. Profit margin for the company is 16.75%. Distance from 52-week low is 6.97% and -9.32% from its 52-week high. The company has generated returns on investments over the last 12 months (14.47%).
Johnson & Johnson quarterly earnings per share for the current quarter are estimated at 2.04 with sales reaching $22.45B over the same period.The EPS is expected to grow by 0.33% this year, but quarterly earnings will post 4.26% year-over-year. Quarterly sales are estimated to grow 4.93% in year-over-year returns.
4812.0 institutions hold shares in Johnson & Johnson (JNJ), with institutional investors hold 73.04% of the company’s shares. The shares outstanding are 2.41B, and float is at 2.40B with Short Float at 0.75%. Institutions hold 72.98% of the Float.
The top institutional shareholder in the company is VANGUARD GROUP INC with over 229.04 million shares valued at $33.48 billion. The investor’s holdings represent 9.5109 of the JNJ Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 198.19 million shares valued at $28.97 billion to account for 8.2297 of the shares outstanding. The other top investors are STATE STREET CORP which holds 133.09 million shares representing 5.5266 and valued at over $19.45 billion, while GEODE CAPITAL MANAGEMENT, LLC holds 2.2881 of the shares totaling 55.1 million with a market value of $8.03 billion.
Johnson & Johnson (JNJ) Insider Activity
The most recent transaction is an insider sale by Decker Robert J, the company’s VP Corporate Controller. SEC filings show that Decker Robert J sold 5,635 shares of the company’s common stock on Aug 30 ’24 at a price of $165.06 per share for a total of $0.93 million. Following the sale, the insider now owns 18973.0 shares.
Still, SEC filings show that on Mar 13 ’24, Broadhurst Vanessa (EVP, Global Corp Affairs) disposed off 8,891 shares at an average price of $162.16 for $1.44 million. The insider now directly holds 15,043 shares of Johnson & Johnson (JNJ).
